How to trade this agriculture stock that rallied on tariff headlines using options

Bunge Global (BG) pre-announced a recast of its full-year 2025 adjusted EPS guidance to $7.30-$7.60, a slight downward adjustment from the prior $7.75 but largely in line with analyst consensus, driven by the ongoing integration of its Viterra merger and segment restructuring. The market reacted positively, with BG shares surging nearly 13.5%, reflecting investor relief over minimal dilution from merger-related adjustments. Despite this short-term upside, the revised guidance still implies a significant year-over-year profit decline, and the company faces broader headwinds from volatile global commodity markets, elevated input costs, and softening demand, suggesting a potential period of consolidation for the stock.

Analysis

Bunge Global (BG) pre-announced a recast of its full-year 2025 adjusted EPS guidance to $7.30-$7.60, a modest downward adjustment from the prior $7.75, yet aligning closely with analyst consensus of $7.47. This update, driven by the Viterra merger integration and segment restructuring, prompted a significant market reaction, with BG shares surging nearly 13.5%. The positive movement primarily reflects investor relief over minimal dilution from merger-related adjustments, rather than an improved fundamental outlook.

Despite the short-term market optimism, the revised guidance implies a substantial year-over-year profit decline, with the midpoint representing a nearly 19% drop from FY2024, which itself saw a 27% decline from FY2023. Bunge faces persistent headwinds, including volatile global commodity markets, fluctuating soybean and oilseed prices, elevated input costs, and softening demand from key markets like China. The $7.3 billion Viterra acquisition also presents ongoing integration challenges.

Technically, the stock is likely to encounter resistance near $100 per share, a level from which it gapped lower following a disappointing Q2 2024 outlook. The pre-announcement price may now act as support, suggesting a potential period of consolidation. This range-bound outlook is reinforced by historical patterns in the agribusiness sector and broader macroeconomic pressures.

Key Decisions for Investors

• Investors should recognize the recent stock surge as relief-driven rather than indicative of a fundamental turnaround, given the continued year-over-year earnings decline and persistent industry headwinds.
• Monitor Bunge's ability to integrate Viterra and manage commodity price volatility, as these factors will be critical for future performance beyond the current range-bound outlook.
• Consider strategies that capitalize on a potentially consolidating price range, such as options strategies like selling strangles, acknowledging the technical resistance at $100 and potential support at pre-announcement levels.